Загрузка...
Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report
BACKGROUND: Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised causing them to be more susceptible to a host of infections. As a precautionary measure, many clinical studi...
Сохранить в:
| Опубликовано в: : | J Med Case Rep |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7894235/ https://ncbi.nlm.nih.gov/pubmed/33608053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-020-02598-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|